Nurix Therapeutics Inc [NRIX]
Pivot duomenys
Pivot statistika
| Rodiklis | Vidurkis | Mediana | Stand. nuokr. |
|---|---|---|---|
| Prieaugis % | 18.21% | 18.21% | 2.36% |
| Nuostolis % | -17.57% | -17.57% | 0.00% |
| Trukmė | 10.0d | 10d | 3.0d |
| Rasta pivot taškų | 4 |
| Prieaugio/nuostolio atkarpos | 3 (2 Prieaugis / 1 Nuostolis) |
| Paskutinis pivot | Top @ $17.55 data 2026-06-18 |
| Pokytis nuo paskutinio pivot | $0.00 (0.00%) |
Kito pivot prognozė Paskutinė: $0.00
| Prognozuojamas kitas tipas | Bottom |
| Prognozuojama kaina (vid.) | $14.47 |
| Prognozuojama kaina (mediana) | $14.47 |
| Prognozuojamas kainos intervalas (~68%) | $14.47 - $14.47 |
| Pokytis iki vidutinio tikslo | $14.47 (N/A) |
| Prognozuojama data (vid.) | 2026-06-28 |
| Prognozuojamas datos intervalas (~68%) | 2026-06-25 - 2026-07-01 |
| Pagrindas | Based on 1 historical losses (Avg: -17.57%, Median: -17.57%, StdDev of Abs: 0.00%) and duration (Avg: 10.0 days, StdDev: 3.0 days) |
| Pastaba | Ranges assume ~normal distribution & historical patterns repeat. Use with caution. |
Nurix Therapeutics Inc rose moderately, up 2.51% on Thursday.
Nurix Therapeutics Inc (NRIX) stock price recorded a solid gain on Thursday after the stock rose $0.430 (2.51%) from the previous session on normal volume. The stock slightly outperformed the market today, moving slightly ahead of the NASDAQ's 1.91% rise.(The stock has risen 3 days straight. This extended rally increases the chances of a price pullback soon) Yesterday's trading volume was 4.25M shares, worth about $74.60M. This represents 1.74M shares more than the day before. Volume was close to the 10-day average of 4.79M shares.
Nurix Therapeutics Inc signals
There is no conclusive signals given from RSI. The price is above both the short- and long-term averages, and the short-term average is above the long-term average, confirming an established up-trend. Strong Bullish Consensus: A powerful wave of positive momentum is evident across all timeframes. Technical indicators are decisively bullish in the short-term (17/30, net +53.3%), medium-term (17/30, net +53.3%), and long-term (17/30, net +53.3%), signaling a robust and sustained uptrend.
Nurix Therapeutics Inc Support & Resistance Levels
The stock is trading above the closest support level at $17.00. approximately $0.550 (3.13%) away. This suggests it is currently acting as a floor, approaching it.The sup dis das support s117 -
Nurix Therapeutics Inc Evaluation
- Trumpas balas: 4.90
- Vidutinis balas: 5.88
- Ilgas balas: 5.56